A Study on Tuberculosis (Rajyakshma)Diagnosis and the benefits of Agastya Haritaki in Supporting ATT.

A Nidan Panchatamak Adhayayan of Rajyakshma and to assess the adjuvant effect of Agastya Haritaki in patients taking ATT w.s.r.to Pulmonary Tuberculosis - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079122

Enrollment

Registered

2025-01-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: i. Patients having signs and symptoms of Rajayakshna. ii. Patients in the age group between 16-70 years. iii. Patients willing to participate in trial.

Exclusion criteria

Exclusion criteria: i. Patients not willing for the trial. ii. Patients below age of 16 years and above 70 years of age.

Design outcomes

Primary

Measure	Time frame
Relief in symptoms of rajyakshmaTimepoint: 60 Days	—

Secondary

Measure	Time frame
Immunity boosterTimepoint: every 30 days upto 8 weeks	—

Countries

India

Contacts

Public ContactDr Rajesh Kumar Manglesh

Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital

drrkmanglesh@gmail.com9816324204

Outcome results